Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis PigmentosaCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosaActive, not recruitingPhase 32026-07-31NCT06388200

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Ocugen6

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Advanced Research, LLC.Deerfield BeachUnited States1
Associated Retina ConsultantsPhoenixUnited States21
Bascom Palmer Eye Institute, University of Miami, Miller School of MedicineMiamiUnited States1
Baylor College of MedicineHoustonUnited States306
Calgary Retina ConsultantsCalgaryCanada1
Erie Retina Research LLCErieUnited States1
Gundersen Health SystemLa CrosseUnited States11
Research Institute of the McGill University Health CentreMontrealCanada1
Retina Consultants of TexasBellaireUnited States24
Retina Foundation of the SouthwestDallasUnited States38
Sunnybrook Health Sciences CentreTorontoCanada167
The University of British ColumbiaVancouverCanada1
University of AlbertaEdmontonCanada1
University of Southern CaliformiaLa JollaUnited States1
University of Southern California, Roski Eye InsituteLos AngelesUnited States1
Valley Retina InstituteMcAllenUnited States12
Vanderbilt Eye InstituteNashvilleUnited States12